Startseite PurA sensitizes cells to toxicity induced by oxidative stress
Artikel Open Access

PurA sensitizes cells to toxicity induced by oxidative stress

  • Hawra Albukhaytan , Bahareh Torkzaban , Ilker K. Sariyer EMAIL logo und Shohreh Amini EMAIL logo
Veröffentlicht/Copyright: 23. März 2023
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objectives

PurA is an evolutionary conserved protein that is known to bind to single stranded DNA or RNA and regulate both transcription and translation. PurA has been implicated in many neurological and neurodevelopmental deficits, but its role in response to cellular stress has not yet been clarified. In this study, we have studied the cells’ stress response in the presence and absence of PurA expression.

Methods

Oxidative stress was induced in MEF cells obtained from PURA WT and K/O mice by paraquat treatments. The cellular response to stress was determined and compared by viability assays, immunocytochemistry and biochemical analyses.

Results

Interestingly, paraquat treated PurA expressing MEF cells showed higher sensitivity and less cellular viability than those with no PurA expression. Moreover, western blot analysis revealed increase in the expression of the apoptotic marker cleaved caspase 3 and autophagy marker LC3-II in PurA WT MEF cells compared to the PurA K/O MEF cells under oxidative stress induction.

Conclusions

Our observations indicate that PurA may play a key role in regulating cellular toxicity induced by oxidative stress and emphasize its importance for cell-fate determination under cytotoxic stress conditions.

Introduction

Pur-Alpha (PurA) is a ubiquitous protein that comprises of 322 amino acids and binds to DNA and RNA sequences [13]. It is an evolutionary conserved protein that has the same sequences among species from bacteria to humans [1, 4, 5]. PurA is one of the four members of Pur family proteins: Pur-Alpha or PurA, Pur-beta or PurB, and two forms of Pur-gamma or Purg [1], [2], [3], [4, 6]. The protein has a role in both transcription [79] and translation and can function as a transcriptional activator in human cells [4]. PurA plays a crucial role in regulating the development of the central nervous system components [3], and mutations in this protein have been shown to be linked to multiple neurodevelopmental and neurodegenerative disorders [3, 6, 10, 11].

Excess amounts of Pur-Alpha prevent the growth of cancer cells and block their proliferation; thus, it is considered as a tumor suppressor protein [6, 7, 12]. Pur-alpha is known to contribute to the pathogenesis of several neurological and neurotropic viral diseases including ALS [8, 11, 13], HIV/AIDS, and progressive multifocal leukoencephalopathy (PML) [14]. It was suggested that Pur-alpha plays a role in controlling and regulating cell cycle [3, 7, 15, 16] and cellular differentiation by colocalizing and association with Cdk protein kinases [2]. Pur-Alpha has been found to be an essential protein in the development of mammalian brain [4], and based on existing evidence, PurA acts as a neuroprotective factor [11]. Mutations in Pur-alpha cause many neurodevelopmental disorders (PURA-NDDs), these disorders are caused by PURA pathogenetic variants [10, 17]. PURA-NDDs include 5q31.3 deletion syndrome [3] and PURA syndrome [10, 18]. Very few patients are reported worldwide with the 5q31.3 micro deletion syndrome while an increasing number of patients are steadily diagnosed with PURA syndrome [11]. PURA syndrome is a condition of a delayed development and intellectual disability plus abnormality in motor and speech skills in children [17, 19, 20]. Those children with PURA syndrome express abnormalities in some important organs in the body such as organs in the urinary, cardiovascular, and gastrointestinal systems [17, 20]. MRI brain scan of children with PURA syndrome shows frequent dysmaturation and delayed development or decrease in the cortical white matter [11, 18]. In addition to its importance in CNS pathologies, PurA has been reported to contribute to impairment of muscle cells and tissues [11]. PurA is a ubiquitously expressed protein in humans and functionally crucial for different processes involved in many neurodevelopmental and neurodegenerative disorders [3, 11].

In order to further elaborate on cellular functions of Pur-alpha, in this study, we examined how the presence of PurA is affecting cell’s response to cytotoxic stress by utilizing cells derived from PurA wild-type and knock-out mice. Our results suggest that the absence of PurA expression causes resistance to the cytotoxicity induced by oxidative stress. These results suggest that PurA may play a critical role in cell-fate determination under stress conditions and may warrant further investigation on its possible roles in cellular differentiation and maturation during development.

Materials and methods

Cell culture

Mouse embryonal fibroblast (MEF) cells were isolated and cultured from the PURA WT and PURA K/O mouse models [2]. MEF cells were grown in DMEM medium with 10% FBS and 1% P/S and maintained in 37 °C humidified incubator with 7% CO2.

Immunoblotting

Whole cell extracts were obtained from both treated or untreated PurA WT and PurA KO MEFs using RIPA buffer and protease inhibitor cocktail. Protein concentration was determined using Bradford assay. We used fifty micrograms of each sample which were denatured by boiling at 95 °C in SDS dye and water. Protein samples were loaded in and separated by 12% SDS-PAGE and then were transferred on either 0.2 or 0.45 μM nitrocellulose membranes. Membranes were blocked with 10% dry milk for 1 h then probed overnight with 0.5% dry milk plus the desired primary antibody, usually 1:1,000 dilution. Next day, after washing the membranes three times with 1X PBST and one time with 1X PBS, 5 min each, we probed membranes with specific secondary antibodies in dry milk, usually 1:10,000 dilution for 1 or 2 h depending on the primary antibody. Subsequently, membranes were scanned using the LICORE CLx instrument.

Immunocytochemistry and microscopy

PurA−/− and PurA +/+ MEFs in two-well chamber slides were washed with PBS and fixed in 4% paraformaldehyde for 15 min and blocked in 5% BSA in PBST. The MEFs were probed with the following antibodies anti-GPCR GPR7 (1:200) (1:1,000, Abcam, Cambridge, MA), and anti- β3-tubulin (1:500) overnight in 4 °C and washed with cold PBST. Alexa Flour Secondary antibodies donkey anti-mouse IgG 484 and donkey anti-rabbit IgG 568 have been applied for fluorescent labeling (Thermo Fisher Scientific, Eugene, OR). VECTASHIELD medium (Vector, Laboratories, Burlingame, CA) was used for DAPI labeling and mounting. Leica fluorescent microscope (Leica Microsystems, IL.) was used for imaging.

MTT assay

MEF cells from PurA +/+ and PurA −/− mice were seeded in 12 well plates (200,000 cells/well) to perform dose response and time course experiment of Paraquat treatment. After treatment with Paraquat, MTT reagent was prepared by dissolving 5 mg of MTT reagent/1 mL of 1X sterile PBS and kept in dark due to its light sensitivity. 1:10 dilution of MTT reagent was added to each well and incubated for 2 h at 37 °C. The MTT solvent was than prepared which contained: 50 mL of 100% isopropanol, 50 μL of NP40, 200 μL of 1 M HCL. After 2 h incubation with MTT reagent, media with MTT reagent were aspirated and 1 mL of MTT solvent was added to each well and was shaken for 30 min at RT covered with foil. Plates were checked every 5 min; the reaction was completed when cells became colorless and the supernatant was purple. We took 1 mL of each well and transferred it to Eppendorf tubes, spun down, and then transferred 200 μL to a 96 well plate to read on spectrophotometer or plate reader.

Antibodies

Cleaved Caspase 3, rabbit, R&D #KHK0821081. LC3, rabbit, Sigma, #0000123445. Caspase 3, rabbit, R&D #AK00521051. Alpha-tubulin, mouse, Invitrogen, #UF0290206. BAG3, rabbit, LC3, rabbit, Sigma L8918, 0000123445. G&M 680, Invitrogen, TI1266544. G&R 680, Invitrogen, T1271935. R&G 800, Invitrogen, S62415222A. PurA, mouse, 10B12, was a kind gift from Dr. Edward M, Johnson, Eastern Virginia med school, Norfolk, Virginia. BAG3, rabbit, Protech, 10599-I-AP. PurA, rabbit, Abcam, ab79936.

Reagents

Oxidative stress was induced by Paraquat dichloride hydrate, Sigma Aldrich, CAS # 75365-73-0. Heat shock response was induced by GGA, Geranylgeranylacetone, Sigma Aldrich, CAS# 6809-52-5.

Statistical analysis

Results are expressed as Mean ± SEM. T-test was used for the comparison of two unpaired groups. One-way ANOVA was used to compare three non-paired groups followed by a post-hoc Tukey HSD test. p value <0.05 was considered significant.

Results

Effects of heat-shock and oxidative stress on MEF cells derived from PURA-WT and K/O

PurA mouse model was generated by [2] research group through targeted disruption of PURA gene by homologous recombination in embryonic stem cells (ES). The transgenic animals were lacking either one allele of PurA (PURA+/−) or both alleles (PURA−/−). In our study, we used the primary mouse embryo fibroblasts (MEFs) which were derived from the embryos of mouse models PurA WT (PURA+/+) and PurA KO (PURA−/−). The PURA phenotype of both cells was confirmed by PurA Western blotting (Figure 1A). As expected, PURA k/o MEF cells were negative for PurA expression. To gain insight into the effect of stress induced by Geranylgeranylacetone (GGA) which mimics heat-shock conditions, cells were treated with GGC and immunocytochemistry was performed for PurA in both WT and k/o cells. Results suggested that GGA treatment had no visible effects on PurA expression in WT cells (Figure 1B) and their morphology was indistinguishable in both WT and k/o cells (Figure 1C). In addition, PURA WT and k/o cells were also treated with Paraquat which induces oxidative stress, and phase contrast images were taken to monitor cellular responses to the treatment. As shown in Figure 1D, while paraquat treatment caused a significant alteration in cellular morphology with obvious cytotoxicity in PurA-WT cells, there were limited cytotoxicity observed in k/o cells.

Figure 1: 
Effects of heat-shock and oxidative stress on PURA WT and PURA K/O MEF cells. (A) PurA expression in MEF cells. Western blot analysis of PurA expression in PURA WT and PURA K/O cells. (B) and (C) Immunocytochemical analysis of PurA expression in control and GGA treated PURA WT (B) and PURA K/O (C) MEF cells. (D) Phase contrast images of PURA WT and PURA K/O MEF cells treated with Paraquat. All images are representative of three independent experiments.
Figure 1:

Effects of heat-shock and oxidative stress on PURA WT and PURA K/O MEF cells. (A) PurA expression in MEF cells. Western blot analysis of PurA expression in PURA WT and PURA K/O cells. (B) and (C) Immunocytochemical analysis of PurA expression in control and GGA treated PURA WT (B) and PURA K/O (C) MEF cells. (D) Phase contrast images of PURA WT and PURA K/O MEF cells treated with Paraquat. All images are representative of three independent experiments.

PurA expressing MEFs are more sensitive to oxidative stress compared to PurA knockout MEFs

Oxidative stress was induced on both PurA expressing MEFs and PurA knockout MEFs using Paraquat drug in a dose (0.5, 1.0, and 1.5 mM) and time (4, 8, 18, 24, and 24 h) dependent manner. PurA WT and KO MEFs were treated with paraquat when the cells were about 85% confluent. MTT assays were performed to determine relative cell’s viability under all examined conditions in both PurA WT and PurA K/O MEFs. MTT results showed that the relative cell viability in the presence of PurA was significantly reduced in PurA WT MEFs in a time and dose dependent manner when compared to the control or non-treated samples. By the 24 h treatments, cell viability was reduced to 20% viable cells with 1.5 mM Paraquat treatment. On the other hand, although paraquat treatments resulted in a significant reduction in cell viability in a dose and time dependent manner, cell viabilities at 24 h with 1.5 mM paraquat treatment was about 50% in PurA K/O cells compared to the WT cells (Figure 2). These results suggest that cytotoxicity induced by oxidative stress is clearly more pronounced in PurA expressing MEF cells than cells with no PurA expression.

Figure 2: 
Time and dose dependent effect of Paraquat treatment on cellular viability of PURA WT and PURA K/O MEF cells. PURA WT (A) and PURA K/O (B) MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, MTT assays were performed to determine cellular viabilities and presented as bar graph. Data are shown as mean ± SEM (n=3).
Figure 2:

Time and dose dependent effect of Paraquat treatment on cellular viability of PURA WT and PURA K/O MEF cells. PURA WT (A) and PURA K/O (B) MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, MTT assays were performed to determine cellular viabilities and presented as bar graph. Data are shown as mean ± SEM (n=3).

Apoptosis and autophagy activation in PurA-WT and K/O cells in response to oxidative stress

The effect of oxidative stress on apoptosis was determined by biochemically analyzing the expression of apoptotic marker, cleaved caspase 3, in the presence and absence of PurA in MEFs. PurA expressing MEFs and PurA knockout MEFs were treated with increasing doses of paraquat (0, 0.5, 1, 1.5 mM) and whole cell protein lysates were extracted at 4,8,18, and 24 h post treatments. Western blot analyses were performed to determine the activation of apoptosis under all treatment conditions using an antibody against the Cleaved caspase 3. In both WT and KO MEFs, Cleaved caspase 3 was not detected at 4 and 8 h of paraquat treatments (Figures 3 and 4). Cleaved caspase 3 expressions were mainly induced at 18 and 24 h post treatments. Western blot analysis revealed a notable increase in the expression of cleaved caspase 3, and correlated with the increased concentrations of Paraquat treatments in MEF cells (Figures 3 and 4, panels B and C). In agreement with the viability assays (Figure 2), cleaved caspase 3 activation in response to paraquat treatments was significantly higher in PurA expressing MEFs than PurA k/o MEFs (compare Figure 3B with Figure 4B).

Figure 3: 
Effect of oxidative stress on induction of apoptosis and autophagy in PURA WT MEF cells. (A) PURA WT MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, protein lysates were prepared and western blot analyses were performed for the detection of PurA, cleaved caspase 3, total caspase 3, and LC3-I/II. Beta-actin was probed in the same membranes as loading control. The band intensities of cleaved caspase 3 (B), total caspase 3 (C), LC3-I (D), and LC3-II (E) were determined, normalized to B-actin, and represented as bar graph. (F). The LC3-II/LC3-I ratios were calculated and shown as bar graph. Data are shown as mean ± SEM (n=3).
Figure 3:

Effect of oxidative stress on induction of apoptosis and autophagy in PURA WT MEF cells. (A) PURA WT MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, protein lysates were prepared and western blot analyses were performed for the detection of PurA, cleaved caspase 3, total caspase 3, and LC3-I/II. Beta-actin was probed in the same membranes as loading control. The band intensities of cleaved caspase 3 (B), total caspase 3 (C), LC3-I (D), and LC3-II (E) were determined, normalized to B-actin, and represented as bar graph. (F). The LC3-II/LC3-I ratios were calculated and shown as bar graph. Data are shown as mean ± SEM (n=3).

Figure 4: 
Effect of oxidative stress on apoptosis and autophagy induction in PURA K/O MEF cells. (A) PURA K/O MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, protein lysates were prepared and western blot analyses were performed for the detection of PurA, cleaved caspase 3, total caspase 3, and LC3-I/II. Beta-actin was probed in the same membranes as loading control. The band intensities of cleaved caspase 3 (B), total caspase 3 (C), LC3-I (D), and LC3-II (E) were determined, normalized to B-actin, and represented as bar graph. (F). The LC3-II/LC3-I ratios were calculated and shown as bar graph. Data are shown as mean ± SEM (n=3).
Figure 4:

Effect of oxidative stress on apoptosis and autophagy induction in PURA K/O MEF cells. (A) PURA K/O MEF cells were treated with increasing doses of Paraquat (0, 0.5, 1, 1.5 mM). At 0, 4, 8, 18, and 24 h post treatments, protein lysates were prepared and western blot analyses were performed for the detection of PurA, cleaved caspase 3, total caspase 3, and LC3-I/II. Beta-actin was probed in the same membranes as loading control. The band intensities of cleaved caspase 3 (B), total caspase 3 (C), LC3-I (D), and LC3-II (E) were determined, normalized to B-actin, and represented as bar graph. (F). The LC3-II/LC3-I ratios were calculated and shown as bar graph. Data are shown as mean ± SEM (n=3).

In the same set of experiments, expression of autophagy marker LC3-I and LC3-II was also analyzed in parallel with cleaved caspase 3. As shown in Figure 3D and E, while there was no significant alteration in LC3-I expression, LC3-II expressions were induced in PurA expressing MEF in response to increasing doses of paraquat treatment at 24 h post treatments. Analysis of LC3-II/LC3-I ratios further verified the autophagy induction in those cells (Figure 3F). Interestingly, unlike PurA expressing MEFs, PurA k/o MEFs showed no significant alteration in either LC3-I or LC3-II expression under the same paraquat treatment conditions (Figure 4, lanes D–F). These results suggest that autophagy induction in PurA expressing cells under oxidative stress conditions is also more pronounced than those with PurA k/o cells.

Discussion

PurA, the sequence specific single stranded DNA and RNA binding protein is an important protein for cell viability and cell’s crucial processes such as transcription, translation, and proliferation [16, 21]. When microinjected or overexpressed, PurA was reported to play a role in blocking proliferation at cell cycle checkpoints either G1-S or G2-M, also inhibiting the growth of oncogenically transformed cells [4, 7]. Mutations in PurA have many effects on cellular functions, and it clearly has important roles in development of many neurological diseases [12, 21].

It was shown that PurA plays a role in brain diseases that involves neurons and glial cells such as fragile X syndrome and a form of amyotrophic lateral sclerosis/fronto-temporal dementia [4]. Lack of PurA has been reported to increase the sensitivity to UVC irradiation, also making cells more sensitive to DNA replication inhibitors such as hydroxyurea [21] because of its involvement in the common pathways for DNA replication [9, 21]. Many studies previously reported the involvement of PurA in cell cycle [2, 7], DNA replication [21], oncogenic transformation [9], in cell’s response to DNA damage by giving resistance to the DNA damage-inducing cancer chemotherapy [21]. There are several ways in which cells can use in response to any stress to eliminate cell’s damages, those include the activation of survival pathways, and the initiation of cell death [22, 23]. Stressed cells can use many cell death mechanisms to handle the stress such as apoptosis, necrosis [23], and autophagy [22].

Our results suggest that PurA WT MEFs are more sensitive and less resistant to oxidative stress than those lacking PurA expression. This is most likely due to the fact that PurA might be controlling the cellular behavior in response to stress through the initiation of cell death pathways. The robust activation of the apoptotic marker cleaved caspase 3 and autophagic marker LC3-II further suggests that PurA might be a critical protein for the initiation of apoptosis and autophagic pathways. Autophagy is an active cellular process which neurons and glial cells depend on for the elimination of pathological protein aggregates, and defect in this process contributes to the incidence of neurodegenerative disorders [24]. For example, dysregulation of autophagy pathways has been associated with the initiation of neurodegenerative diseases, such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) [25, 26]. Interestingly, our results reveal that pur-alpha expression may be required for proper induction of autophagy in response to oxidative stress. This suggests that PurA gene expression may have a critical role in the regulation of autophagy, and warrants further investigation into its involvement in neurodegenerative disorders including AD and PD.


Corresponding authors: Dr. Ilker K. Sariyer, Department of Microbiology, Immunology, and Inflammation, Comprehensive NeuroHIV Center (CNHC), Center for Neurovirology & Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA, E-mail: ; and Dr. Shohreh Amini, Director, Vice President, Department of Microbiology, Immunology, and Inflammation, Comprehensive NeuroHIV Center (CNHC), Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA; and PSM Program in Biotechnology, Temple Faculty Senate, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA, E-mail:

Funding source: National Institute of Health

Award Identifier / Grant number: P30MH092177-11

Acknowledgments

The authors wish to thank past and present members of the Department of Microbiology, Immunology, and Inflammation/Center for Neurovirology, and Gene Editing for sharing of reagents and ideas. This study utilized services offered by core facilities of the Comprehensive NeuroHIV Center (CNHC NIMH Grant Number P30MH092177-11). The authors are grateful to the King Saud Bin Abdul-Aziz University for Health Sciences, Saudi Arabia for the scholarship granted to HA.

  1. Research funding: This work was supported, in part, by grants awarded by the NIH to SA and IKS.

  2. Author contributions: Conceived and designed the experiments: SA, HA, and IKS. Performed the experiments: HA and BT. Analyzed the data: HA, IKS, and SA. Contributed reagents/materials/analysis tools: IKS and SA. Wrote the paper: HA, IKS, and SA.

  3. Competing interests: The authors have declared that no competing interests exist.

References

1. Gallia, GL, Johnson, EM, Khalili, K. Survey and Summary: purα: a multifunctional single-stranded DNA-and RNA-binding protein. Nucleic Acids Res 2000;28:3197–205.10.1093/nar/28.17.3197Suche in Google Scholar PubMed PubMed Central

2. Khalili, K, Del Valle, L, Muralidharan, V, Gault, WJ, Darbinian, N, Otte, J, et al.. Purα is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol 2003;23:6857–75.10.1128/MCB.23.19.6857-6875.2003Suche in Google Scholar PubMed PubMed Central

3. Yuan, C, Li, P, Guo, S, Zhang, B, Sun, T, Cui, J. The role of PurÃfŽÃ, ±in neuronal development, the progress in the current researches. J Neurol Neurosci 2016;7:5.10.21767/2171-6625.1000152Suche in Google Scholar

4. Daniel, DC, Johnson, EM. PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions. Gene 2018;643:133–43.10.1016/j.gene.2017.12.004Suche in Google Scholar PubMed PubMed Central

5. Wortman, MJ, Hanson, LK, Martínez-Sobrido, L, Campbell, AE, Nance, JA, García-Sastre, A, et al.. Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals. BMC Mol Biol 2010;11:1–15.10.1186/1471-2199-11-81Suche in Google Scholar PubMed PubMed Central

6. Johnson, EM, Daniel, DC, Gordon, J. The pur protein family: genetic and structural features in development and disease. J Cell Physiol 2013;228:930–7.10.1002/jcp.24237Suche in Google Scholar PubMed PubMed Central

7. Darbinian, N, Gallia, GL, King, J, Del Valle, L, Johnson, EM, Khalili, K. Growth inhibition of glioblastoma cells by human Purα. J Cell Physiol 2001;189:334–40.10.1002/jcp.10029Suche in Google Scholar PubMed

8. Di Salvio, M, Piccinni, V, Gerbino, V, Mantoni, F, Camerini, S, Lenzi, J, et al.. Pur-alpha functionally interacts with FUS carrying ALS-associated mutations. Cell Death Dis 2015;6:e1943.10.1038/cddis.2015.295Suche in Google Scholar PubMed PubMed Central

9. Hokkanen, S, Feldmann, HM, Ding, H, Jung, CK, Bojarski, L, Renner-Müller, I, et al.. Lack of Pur-alpha alters postnatal brain development and causes megalencephaly. Hum Mol Genet 2012;21:473–84.10.1093/hmg/ddr476Suche in Google Scholar PubMed

10. Choi, SA, Lee, HS, Park, TJ, Park, S, Ko, YJ, Kim, SY, et al.. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders. Brain Dev 2021;43:912–8.10.1016/j.braindev.2021.05.009Suche in Google Scholar PubMed

11. Molitor, L, Bacher, S, Burczyk, S, Niessing, D. The molecular function of PURA and its implications in neurological diseases. Front Genet 2021;12:267.10.3389/fgene.2021.638217Suche in Google Scholar

12. White, MK, Johnson, EM, Khalili, K. Multiple roles for Pur-α in cellular and viral regulation. Cell Cycle 2009;8:414–20.10.4161/cc.8.3.7585Suche in Google Scholar

13. Daigle, JG, Krishnamurthy, K, Ramesh, N, Casci, I, Monaghan, J, Mcavoy, K, et al.. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity. Acta Neuropathol 2016;131:605–20.10.1007/s00401-015-1530-0Suche in Google Scholar

14. Sariyer, IK, Sariyer, R, Otte, J, Gordon, J. Pur-alpha induces JCV gene expression and viral replication by suppressing SRSF1 in glial cells. PLoS One 2016;11:e0156819.10.1371/journal.pone.0156819Suche in Google Scholar

15. Mishra, M, Del Valle, L, Otte, J, Darbinian, N, Gordon, J. Pur-alpha regulates RhoA developmental expression and downstream signaling. J Cell Physiol 2013;228:65–72.10.1002/jcp.24105Suche in Google Scholar

16. Muralidharan, V, Cort, L, Meier, E, Blankenhorn, EP, Khalili, K. Molecular characterization and chromosomal localization of mouse Purα gene. J Cell Biochem 2000;77:1–5.10.1002/(SICI)1097-4644(20000401)77:1<1::AID-JCB1>3.0.CO;2-LSuche in Google Scholar

17. Cinquina, V, Ciaccio, C, Venturini, M, Masson, R, Ritelli, M, Colombi, M. Expanding the PURA syndrome phenotype: a child with the recurrent PURA p. (Phe233del) pathogenic variant showing similarities with cutis laxa. Mol Genet Genomic Med 2021;9:e1562.10.1002/mgg3.1562Suche in Google Scholar

18. Zhang, W, Li, Y. A clinical analysis and diagnosis course of children with PURA-related neurodevelopmental disorders in Tianjin, China. Research Square 2021. https://doi.org/10.21203/rs.3.rs-445079/v1.Suche in Google Scholar

19. Reijnders, MR, Janowski, R, Alvi, M, Self, JE, Van Essen, TJ, Vreeburg, M, et al.. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature. J Med Genet 2018;55:104–13.10.1136/jmedgenet-2017-104946Suche in Google Scholar

20. Reijnders, MR, Leventer, RJ, Lee, BH, Baralle, D, Selber, P, Paciorkowski, AR, et al.. PURA-related neurodevelopmental disorders. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2017: 1993–2023p.Suche in Google Scholar

21. Kaminski, R, Cheeseboro, L, Amini, S, Johnson, EM, White, MK, Khalili, K, et al.. Role of Purα in the cellular response to ultraviolet-C radiation. Cell Cycle 2010;9:4164–73.10.4161/cc.9.20.13456Suche in Google Scholar

22. Fulda, S, Gorman, AM, Hori, O, Samali, A. Cellular stress responses: cell survival and cell death. Int J Cell Biol 2010;2010: 20182529.10.1155/2010/214074Suche in Google Scholar PubMed PubMed Central

23. Martindale, JL, Holbrook, NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1–15.10.1002/jcp.10119Suche in Google Scholar PubMed

24. Goldsmith, J, Ordureau, A, Harper, JW, Holzbaur, ELF. Brain-derived autophagosome profiling reveals the engulfment of nucleoid-enriched mitochondrial fragments by basal autophagy in neurons. Neuron 2022;110:967–76.e8. https://doi.org/10.1016/j.neuron.2021.12.029.Suche in Google Scholar PubMed PubMed Central

25. Nixon, RA, Wegiel, J, Kumar, A, Yu, WH, Peterhoff, C, Cataldo, A, et al.. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005;64:113–22. https://doi.org/10.1093/jnen/64.2.113.Suche in Google Scholar PubMed

26. Pradas, E, Martinez-Vicente, M. The consequences of GBA deficiency in the Autophagy-lysosome system in Parkinson’s disease associated with GBA. Cells 2023;12:191.10.3390/cells12010191Suche in Google Scholar PubMed PubMed Central

Received: 2022-12-20
Accepted: 2023-02-17
Published Online: 2023-03-23
Published in Print: 2023-06-26

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Heruntergeladen am 17.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/nipt-2022-0020/html
Button zum nach oben scrollen